PRWeb: Medical Pharmaceuticals http://www.prweb.com Latest news releases for Medical Pharmaceuticals from PRWeb en PRWeb Distribution Newswire http://www.prweb.com/images_v4/prweb_logo_hv2.jpg http://www.prweb.com 200 46 xml@emediawire.com xml@emediawire.com Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever http://www.prweb.com/releases/Nutra_Pharma/OTC_pain_reliever/prweb3210214.htm Nutra Pharma has announced its intention to begin the drug registration process in Brazil and Colombia for its over-the-counter pain reliever. The company is currently marketing a similar analgesic, Cobroxin, in the United States for the treatment of moderate to severe (Stage 2) chronic pain. (PRWeb Nov 16, 2009)

Read the full story at http://www.prweb.com/releases/Nutra_Pharma/OTC_pain_reliever/prweb3210214.htm

]]> Baxa Announces 2010 Course Dates and Discounted Pricing for its STAR Center® Training Facility http://www.prweb.com/releases/2009/11/prweb3201704.htm Baxa Corporation announces the 2010 course dates for its STAR Center training programs. Together with the United States Pharmacopeia (USP), the company plans 10 class sessions focused on pharmacy best practices in relation to USP 797 regulatory compliance and hazardous drug handling. To meet the needs of budget-sensitive hospitals, 2010 participants will be able to register for the Aseptic Processing and Compliance Tools for USP 797 course at a newly discounted price of $1,875; a 10% discount from standard pricing. Participants earn 21 hours of CE credit. (PRWeb Nov 16, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3201704.htm

]]> Federal Court Appoints Onder Law Firm Partner as Co-Lead Counsel to the Plaintiffs' Steering Committee of the Multi-District Litigation for Yasmin and Yaz Litigation http://www.prweb.com/releases/yaz/lawsuit/prweb3207584.htm Mark Niemeyer, a partner at Onder, Shelton, O’Leary & Peterson, LLC, has been appointed to the Plaintiffs' Steering Committee in the consolidated Yasmin and Yaz birth control litigation. (PRWeb Nov 15, 2009)

Read the full story at http://www.prweb.com/releases/yaz/lawsuit/prweb3207584.htm

]]> XOLAIR Safety Study Continues to 2012 Despite Increased Rate of Occurrence of Heart Problems, Onder Law Firm Offers Free XOLAIR Case Review http://www.prweb.com/releases/xolair/safety/prweb3207784.htm The FDA is reviewing preliminary safety information on XOLAIR allergic asthma medication. Problems with XOLAIR have been linked to heart attack and stroke. The Onder Law Firm is offering a free case review to those or families of those who may have experienced serious health problems after taking XOLAIR. (PRWeb Nov 15, 2009)

Read the full story at http://www.prweb.com/releases/xolair/safety/prweb3207784.htm

]]> Marcadia Biotech Makes Lead Gift to Establish World-Class Watanabe Biotech Lecture Series at Indiana University http://www.prweb.com/releases/2009/11/prweb3206804.htm A recognized global leader in biotech and the life sciences, Gus Watanabe, MD was a co-founder and chairman of Marcadia Biotech, a bio-pharmaceutical company focused on product development to treat diabetes and obesity, until his death earlier in 2009. To advance and accelerate Watanabe's scientific vision, Marcadia Biotech made the lead gift to establish a world-class annual biotech symposium at Indiana University. The one-day lecture series will be named in honor of the late visionary scientist and entrepreneur. The first symposium will take place at Indiana University's Bloomington campus in the fall of 2010. (PRWeb Nov 15, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3206804.htm

]]> DIA/PhRMA Workshop to Explore Dried Blood Spot Sampling Implementation and Advances http://www.prweb.com/releases/dia_phrma/dried-blood-sampling/prweb3200984.htm The Drug Information Association (DIA), in cooperation with PhRMA, will host a workshop on Dried Blood Spot Sampling in the Pharmaceutical Industry: Methodology, Implementation and Best Practices on December 8, 2009 in Washington, DC. (PRWeb Nov 14, 2009)

Read the full story at http://www.prweb.com/releases/dia_phrma/dried-blood-sampling/prweb3200984.htm

]]> Yaz and Yasmin Birth Control Lawsuits Continue to MountThe Onder Law Firm Will Provide a Free Case Review to Women Suffering from Yaz Side Effects http://www.prweb.com/releases/yaz/lawsuits/prweb3195174.htm It is estimated that legal counsel already represents over 3,500 women and countless others are still in need of help, unaware of their rights, if Yaz, the most popular birth control pill in the United States, affected them adversely. The Onder Law Firm will provide a free case review to women or the families of women who have suffered from serious health problems after taking Yaz. (PRWeb Nov 13, 2009)

Read the full story at http://www.prweb.com/releases/yaz/lawsuits/prweb3195174.htm

]]> Ryogen is Awarded New Patent http://www.prweb.com/releases/2009/11/prweb3191974.htm Patented DNA Sequence Encodes a Protein Implicated in Diabetes, Metabolic Syndrome, Immune Dysfunctions and Other Diseases (PRWeb Nov 13, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3191974.htm

]]> PhysioGenix Names Dr. Magdalena Alonso-Galicia as Senior Study Director http://www.prweb.com/releases/2009/11/prweb3192684.htm Dr. Alonso-Galicia brings eight years of experience at Merck to PhysioGenix, expands cardiovascular and metabolic preclinical research expertise. (PRWeb Nov 13, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3192684.htm

]]> Stemedica President Invited To Lecture At The University Of Oxford http://www.prweb.com/releases/stemedica-presents/oxford-stem-cell-trials/prweb3196604.htm Nikolai Tankovich, MD, Ph.D., President and Chief Medical Officer of Stemedica Cell Technologies, Inc. was invited to lecture at a multi-disciplinary seminar at the Centre for Science and Society at Trinity College, a constituent college of the University of Oxford, England. The seminar, which focused on current research and medical applications for stem cells, was attended by more than 300 professors and staff representing all facets of the University. (PRWeb Nov 12, 2009)

Read the full story at http://www.prweb.com/releases/stemedica-presents/oxford-stem-cell-trials/prweb3196604.htm

]]> The New Pollutants Brewing in Our Water http://www.prweb.com/releases/Potomac_Conservancy/River_Report/prweb3189304.htm Report Discusses Emergence of Endocrine Disruptors in Potomac (PRWeb Nov 12, 2009)

Read the full story at http://www.prweb.com/releases/Potomac_Conservancy/River_Report/prweb3189304.htm

]]> NeoVista, Inc. Announces First Neovascular AMD Patient Treated with VIDION® ANV® Therapy System in Europe Following Commercialization http://www.prweb.com/releases/2009/11/prweb3192374.htm Ophthalmic Clinic in Pisa, Italy is First in Europe to Treat Neovascular AMD Patients with New Epimacular Brachytherapy System (PRWeb Nov 12, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3192374.htm

]]> Promega HaloTag® Protein Purification System Makes it Easier to Purify Difficult-to-Express Proteins http://www.prweb.com/releases/promega/halotag/prweb3191674.htm Promega Corporation announces recently released HaloTag® Protein Purification System that addresses common problems associated with purification of recombinant proteins by enabling the delivery of soluble, functional recombinant target proteins at higher yield and purity. (PRWeb Nov 12, 2009)

Read the full story at http://www.prweb.com/releases/promega/halotag/prweb3191674.htm

]]> Webcast Auction Today with Great Deals on Lab/Pharma Equipment http://www.prweb.com/releases/2009/11/prweb3197764.htm EquipNet is hosting a webcast auction of premium, pre-owned lab and pharmaceutical equipment today, November 12, 2009. Identified as surplus to ongoing operations at Adolor Corporation and Inspire Pharmaceuticals, the late-model equipment represents a significant cost savings over buying the equivalent, new items directly from the manufacturer. (PRWeb Nov 12, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3197764.htm

]]> CHI's Molecular Medicine Tri-Conference Keynote John Crowley Inspires Feature Film Starring Harrison Ford http://www.prweb.com/releases/2009/11/prweb3178864.htm John Crowley, a featured Keynote at this year's Molecular Medicine Tri-Conference, is the inspiration for a new film which will find its way onto the big screen January 22. (PRWeb Nov 11, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3178864.htm

]]> Top Five International Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac http://www.prweb.com/releases/automated/thorough_qt/prweb3116734.htm Positions iCardiac as technology leader in global ECG core lab market with largest number of highly automated QT(sm) studies. (PRWeb Nov 11, 2009)

Read the full story at http://www.prweb.com/releases/automated/thorough_qt/prweb3116734.htm

]]> Neurologists Receive New Patient Education Resources from Vivacare for Epilepsy Awareness Month http://www.prweb.com/releases/epilepsy_education/vivacare_neurologists/prweb3181604.htm Vivacare.com provides leading neurologists with new in-depth patient education tools for their epilepsy patients in honor of Epilepsy Awareness Month. (PRWeb Nov 11, 2009)

Read the full story at http://www.prweb.com/releases/epilepsy_education/vivacare_neurologists/prweb3181604.htm

]]> Hormone Therapy Victims Win Important Appeal http://www.prweb.com/releases/hormone-therapy/hrt-lawsuit/prweb3188274.htm On November 2, 2009, the United States Court of Appeals for the Eighth Circuit issued its long-awaited decision in Scroggin v. Wyeth (Case No. 08-2555). The decision gives the green light for federal trials on Wyeth’s and Pfizer’s hormone therapy (http://www.hkllp.com/hormone-replacement-therapy/) drugs. In affirming judgment on a jury verdict of compensatory damages, the federal appellate court rejected the defendants’ claims that plaintiffs like Donna Scroggin cannot prove that hormone therapy caused their breast cancer. Erik Walker of Hissey Kientz, LLP (http://www.hkllp.com/) in Austin, Texas handled the appeal for Ms. Scroggin, writing her briefs and arguing to the court. (PRWeb Nov 11, 2009)

Read the full story at http://www.prweb.com/releases/hormone-therapy/hrt-lawsuit/prweb3188274.htm

]]> BellBrook Labs Goes 4-for-4 to Win $2.7M in SBIR Grants for HTS and HCA Technologies http://www.prweb.com/releases/2009/11/prweb3180254.htm BellBrook Labs announced that all four of the Small Business Innovative Research grants submitted by the company last year recently had been funded by the National Institutes of Health, for a total of $2.7M. Two grants were awarded for further development of the company's Transcreener high throughput screening (HTS) assay platform for kinases and emerging drug targets. An additional two grants will fund development of highly miniaturized cellular assays for automated high content analysis (HCA) using their novel microchannel array platform, called iuvo. (PRWeb Nov 11, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3180254.htm

]]> Calco Commercial Insurance Services Expands its Brokerage Territory to Include California, New York, Texas and Florida http://www.prweb.com/releases/calcocommercialinsurance/11/prweb3180784.htm Calco Commercial Insurance Services is now licensed in California, Texas, New York and Florida. The breadth of their insuring capabilities includes both regional and global risk exposures for domestic and international clients. (PRWeb Nov 10, 2009)

Read the full story at http://www.prweb.com/releases/calcocommercialinsurance/11/prweb3180784.htm

]]> CenterWatch Honored a Fifth Consecutive Year for Best Healthcare Content http://www.prweb.com/releases/2009CenterWatch/eHealthcare/prweb3181264.htm CenterWatch is a seven-time winner of the prestigious eHealthcare Leadership Award given annually to organizations representing the best web sites dedicated to health care. (PRWeb Nov 10, 2009)

Read the full story at http://www.prweb.com/releases/2009CenterWatch/eHealthcare/prweb3181264.htm

]]> InVitria Reports Expanded Manufacturing Capability to Meet Commercial Demand for Lysobac, an Animal Free Reagent for Bacterial Fermentation http://www.prweb.com/releases/BacterialFermentation/chickenlysozymeHEWL/prweb3182554.htm InVitria's Lysobac is a high potency, animal free and consistent alternative to chicken lysozyme, which is used in bacterial cell lysis. Tests prove Lysobac is greater than 4 times more active than chicken lysozyme and increases protein yield from bacterial fermentation. (PRWeb Nov 10, 2009)

Read the full story at http://www.prweb.com/releases/BacterialFermentation/chickenlysozymeHEWL/prweb3182554.htm

]]> Flu Shot Scheduling Chaos Cured by Appointment-Plus Online Appointment Software http://www.prweb.com/releases/2009/11/prweb3177394.htm Health departments and administrators discover a simple and cost effective solution to the inefficiencies and long lines associated with the distribution of flu and H1N1 vaccinations. (PRWeb Nov 10, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3177394.htm

]]> Houston and Chicago Professionals Honored at Sierra Tucson's "Gratitude for Giving" Breakfast http://www.prweb.com/releases/2009/11/prweb3181814.htm Sierra Tucson (http://www.sierratucson.com/) honors clinicians in Houston and Chicago for their outstanding work in the field of addictions and mental health. The Award winners listed below are recognized for their exceptional contributions. (PRWeb Nov 10, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3181814.htm

]]> Diamondback Drugs Provides Relief for Recent Veterinary Drug Shortages http://www.prweb.com/releases/Diamondback_Drugs/compounding_pharmacy/prweb3183334.htm Diamondback Drugs, a leading national veterinary pharmacy, announced that they will be compounding products to address recent drug shortages in the field of veterinary medicine. (PRWeb Nov 10, 2009)

Read the full story at http://www.prweb.com/releases/Diamondback_Drugs/compounding_pharmacy/prweb3183334.htm

]]> Aprexis Health Solutions, Neighborhood Health Plan, and Medmetrics Health Partners Collaborate to Provide Adherence Program http://www.prweb.com/releases/2009/11/prweb3177304.htm Pioneer in medication adherence provides adherence support to hypertension patients. (PRWeb Nov 10, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3177304.htm

]]> Unidrugs Marks Another Step Forward in Cheap Healthcare http://www.prweb.com/releases/2009/11/prweb3174584.htm Unidrugs.com has made it possible for patients to reduce their healthcare costs by availing of cheaper medicines online by making a comparison of various online retailers. Price comparison charts are emailed instantly to patients to be used as reference for savings. (PRWeb Nov 10, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3174584.htm

]]> Davis Bregman MD Now Offering House Calls in Manhattan http://www.prweb.com/releases/Davis_Bregman/house_calls/prweb3177494.htm Doctor house calls now available in New York City by pain management physician. (PRWeb Nov 9, 2009)

Read the full story at http://www.prweb.com/releases/Davis_Bregman/house_calls/prweb3177494.htm

]]> Tarascon Publishing Releases iPhone Edition of Leading Portable Drug Reference http://www.prweb.com/releases/iPhone/apps/prweb3089834.htm Tarascon™, an imprint of Jones and Bartlett Publishers, today announces the release of the Tarascon Pocket Pharmacopoeia iPhone application, with continuous updates to critical drug dosing information important to health care providers at the point of care facing evolving medical challenges such as H1N1 ("swine flu") and other infectious diseases. (PRWeb Nov 9, 2009)

Read the full story at http://www.prweb.com/releases/iPhone/apps/prweb3089834.htm

]]> The Face of Lung Cancer Support and Information Website Launches to Increase Awareness and Advocacy http://www.prweb.com/releases/2009/11/prweb3170344.htm A new website providing support and information to victims and survivors of lung cancer has been launched at TheFaceofLungCancer.org. The site provides a community for victims and survivors while distilling important information and advocating change in health care policy. (PRWeb Nov 9, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3170344.htm

]]> Datafarm Responds to Health Canada’s Announcement of Hybrid eCTD Submission Procedural Simplification http://www.prweb.com/releases/2009/11/prweb3174844.htm Four of the top 10 pharmaceutical giants use Datafarm for production of Hybrid eCTD submissions to Health Canada. Datafarm’s announcement comes on the heels of last week’s 7th Canadian DIA Annual Meeting where Health Canada stated that, effective immediately, sponsor companies may submit Hybrid eCTD regulatory submissions for New Drug Submission (NDS) applications with no prior permission request. (PRWeb Nov 9, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3174844.htm

]]> Spectrum Pharmacy Products Announces the Distribution Launch of an AC-Powered Tool for Crimping and Decapping of Serum Vials -- The CRIMPenstein™ http://www.prweb.com/releases/2009/11/prweb3177184.htm Spectrum Pharmacy Products announced the distribution launch of a new electric crimper and decapper that will increase productivity and lessen injuries due to the repetitive nature of hand crimping. The Wheaton CRIMPenstein™ (https://www.spectrumrx.com/OA_HTML/ibeCCtpItmDspRte.jsp?a=b&minisite=10040&respid=50578&item=1&itemGrpNum=700863&isSupply=1) has an advanced ergonomic design and is engineered to improve throughput and consistency in compounding pharmacies performing sterile applications that require vials capped with aluminum seals. (PRWeb Nov 9, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3177184.htm

]]> Oncology-focused Biotech Selects Cardiocore as Preferred Provider http://www.prweb.com/releases/2009/11/prweb3172124.htm Leading Core Lab to Provide ECG, ECHO and Scientific Consulting Services (PRWeb Nov 8, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3172124.htm

]]> The New NE-9000 Peristaltic Pump from New Era Pump Systems Maximizes Efficiency For The Home Based Business To The Factory Floor http://www.prweb.com/releases/2009/Pump/prweb3170974.htm New Era Pump Systems, Inc. introduces the NE-9000 Peristaltic Pump (http://syringepump.com/peristaltic.htm) designed for small scale production is great for applications ranging from the home based business, research laboratories to the factory floor (PRWeb Nov 7, 2009)

Read the full story at http://www.prweb.com/releases/2009/Pump/prweb3170974.htm

]]> Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference http://www.prweb.com/releases/2009/11/prweb3163644.htm The agenda for Arrowhead's 2010 Personalized Medicine Partnerships Conference, which is set to take place on February 22-24, 2010 in Philadelphia, has been announced. At this three day conference we will highlight key issues in forming partnerships and engage the best speakers to share their experiences. (PRWeb Nov 6, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3163644.htm

]]> DIA Conference to Explore Components of Risk Management Plans As They Apply to Medicinal Products, Therapeutic Biologics and Vaccines http://www.prweb.com/releases/2009/11/prweb3163264.htm Expert speakers from industry, Health Canada, EMEA, FDA, and PMDA will lead presentations at the 2nd DIA Conference on Harmonization of Risk Management Plans to be held December 10-11, 2009 in Washington, DC. (PRWeb Nov 6, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3163264.htm

]]> Eno Research Announces Publication Showing Activated Clinoptilolite (Zeolite) Safely Removes Toxic Heavy Metals through Urinary Excretion http://www.prweb.com/releases/2009/11/prweb3172484.htm Eno Research has published the results of its recent study in the November issue of the Journal of Nutrition and Dietary Supplements that supports the use of an activated clinoptilolite (Zeolite) to increase urinary excretion of toxic heavy metals. (PRWeb Nov 6, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3172484.htm

]]> GenericsWeb Celebrates 10 years of Excellence in Pharmaceutical Patent Intelligence http://www.prweb.com/releases/2009/11/prweb3163854.htm This month marks the 10 year anniversary of the founding of GenericsWeb as a supplier of premium patent information products and services to the Generic Pharmaceutical Industry. GenericsWeb now has customers in over 40 countries and offices in 3 continents, backed by its operating headquarters in Sydney, Australia. (PRWeb Nov 6, 2009)

Read the full story at http://www.prweb.com/releases/2009/11/prweb3163854.htm

]]> FDA Commissioner Margaret Hamburg to Deliver Keynote Address at DIA 46th Annual Meeting, June 13-17, 2010 in Washington, DC http://www.prweb.com/releases/dia-meeting/margaret-hamburg/prweb3156974.htm Dr. Margaret Hamburg, Commissioner of the US Food and Drug Administration (FDA), will deliver the opening keynote address to more than 8,000 professionals from the biopharmaceutical and related sectors at the Drug Information Association (DIA) 46th Annual Meeting. (PRWeb Nov 5, 2009)

Read the full story at http://www.prweb.com/releases/dia-meeting/margaret-hamburg/prweb3156974.htm

]]> BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification http://www.prweb.com/releases/pharmacoviglance/drugsafety/prweb3161774.htm Drug safety specialty firm BioSoteria announced that its Vice President of eLearning and Informatics earned the Certified Professional in Learning and Performance™ (CPLP) credential from the American Society for Training and Development (ASTD) Certification Institute. Michelle Flewell has more than fifteen years of medical communications and health care training experience and is responsible for the development of the company's online pharmacovigilance curriculum eLadder™ Safety. (PRWeb Nov 5, 2009)

Read the full story at http://www.prweb.com/releases/pharmacoviglance/drugsafety/prweb3161774.htm

]]>